|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation 显示文摘 | Talavera A Friemann R G6mez-Puerta S | 2009 | Cancer Res2009，69，14： | 1 |
| 2 | Nimotuzumab an antitumor antibody that targets the epider- mal growth factor receptor blocks lig and binding while permitting the active receptor conformation 显示文摘 | TalALaver A Friemann R Gomez Puerta S | 2009 | Cancer Res2009，69，14： | 1 |
| 3 | Nimo- tuzumab ,an antitumor antiboby that targets the epidermal growth factor receptor, blocks ligand binding while permit- ting the active receptor conformation显示文摘 | Talavera A Friemann R G6mez-Puerta S | 2009 | Cancer Res2009，69，14： | 1 |
| 4 | Crystal structure of plant pectin methylesterase 显示文摘 | Johansson K EI-Ahmad M Friemann R JOrnvaH H Markovifi O Eklund H | 2002 | FEBS Letters2002，514，2： | 1 |
| 5 | Nimo- tuzumab an antitumor antibody that targets the epidermal growth factor receptor blocks lig and binding while permit- ring the active receptor conformation显示文摘 | Talavera A Friemann R Gomez Puerta S | 2009 | Cancer Res2009，69，14： | 1 |
| 6 | Nimotuzum- ab,on antitumor antibody that tesrgets the epidermal growth factor receptor, blocks ligand binding while permitting the ac- tive receptor conformation 显示文摘 | Talavera A Friemann R Gomez Puerta S et a l | 2009 | Cancer Res2009，69，14： | 1 |
| 7 | Nimo- tuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks lig and binding while permitting the active receptor conformation显示文摘 | TALAVERA A FRIEMANN R GOMEZ PUERTA S | 2009 | Cancer Res2009，69，14： | 1 |
| 8 | Nimotuzumab,an antitumor antibody that targets the epidermal growth factor receptor,blocks ligand binding while permitting the active receptor conformation显示文摘 | Talavera A Friemann R G ó mez-Puerta S | | 0，，14： | 1 |
| 9 | Nimotuzumab, all an-titumor antibody that targets the epiderm al growth factor receptor,blocks lig and binding while perm itting the active receptorb confor-mation 显示文摘 | Talaera A Friemann R Gomeapuerta S | 2009 | Cancer Res2009，69，14： | 1 |
| 10 | Nimotuzumab,an antitumor antibody that targets the epidermal growth factor receptor,blocks lig and binding while permitting the active receptor conformation显示文摘 | TALAVERA A FRIEMANN R GOMEZ PUERTA S | 2009 | Cancer Res2009，69，14： | 1 |
| 11 | Nimotuzumab,an antitumor antibody that targets the epidermal growth factor recep-tor,blocks lig and binding while permitting the active receptor con-formation显示文摘 | Talavera A Friemann R Gomez-Puerta S | | 0，，14： | 1 |
| 12 | Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks lig and binding while permitting the active receptor conforma- tion显示文摘 | Talavera A Friemann R C 6mez-Puerta S | 2009 | Cancer Res2009，69，14： | 1 |
| 13 | Nimotuzumah,an antitumor antibody that targets theepidermal growth factor receptor,blocks ligand bindingwhile permitting the active receptor conformation显示文摘 | Talavera A Friemann R Gomez-Puerta S | 2009 | Cancer Res2009，69，14： | 1 |
| 14 | Nimotuzumab an antitumor antibody that targets the epidermal growth factor receptor blocks lig and binding while permitting the active receptor conformation显示文摘 | Talavera A Friemann R Gomez Puerta S | 2009 | Cancer Res2009，69，14： | 1 |
| 15 | Nimotuzum- ab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation 显示文摘 | Talavera A Friemann R G6mez-Puerta S | 2009 | Cancer Res2009，69，14： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员